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Abstract
Nanographene oxide particles (NGO) were produced via oxidative exfoliation of
graphite. Three different sizes of NGO (300 nm, 200 nm and 100 nm) have been
separated by using probe sonication and sucrose density gradient centrifugation.
There is great interest in functionalized NGO as a nanocarrier for in vitro and
in vivo drug delivery, in order to improve dispersibility and stability of the
nanocarrier platforms in physiological media.
In this study, the NGO particles were covalently functionalized with zero
generation polyamidoamide (PAMAM-G0) and with gelatin via noncovalent
interaction. Spectroscopic techniques have been used to discriminate the chemi-
cal states of NGO prior and after functionalization. The X-ray photoelectron
spectroscopy (XPS) revealed a clear change in the chemical state of NGO after
functionalization, for both covalent and noncovalent approaches. Raman spec-
troscopy gave obvious insight after oxidation of graphite and functionalization
of NGO particles depending on the variation of intensity ratios between D, G
and 2D bands. The Fourier transform infrared spectroscopy (FTIR) exhibited
the presence of oxygen containing functional groups distributed onto graphene
sheets after oxidation of graphite. Furthermore, the FTIR is complementary
with the XPS which performed a strong reduction in the oxygen contents after
functionalization. UV visible spectroscopy was used to understand the binding
capacity of gelatin coated NGO particles.
The Microscopy tools, scanning electron microscopy (SEM) and atomic
force microscopy (AFM) are used to estimate the dimensions of NGO particles
(thickness and lateral width). The nanohybrid systems (NGO-PAMAM and
Gelatin-NGO) loaded with carboplatin (CP) were sought for anticancer activity
investigation in HeLa and neuroblastoma cancer cells respectively. Mesenchymal
stem cells (hMSCs) were used as a model of normal cells. On HeLa cells, the
pristine NGO particles with average widths of 200 nm and 300 nm showed
a cytotoxic effect at low (50 µg.ml−1) and high (100 µg.ml−1) concentrations.
While the pristine NGO sample with an average width of 100 nm revealed no
significant cytotoxicity at 50 µg.ml−1, and only recorded a 10% level at 100
µg.ml−1.
The mesenchymal stem cells showed less than 35% viability for all size
distributions. After functionalization with PAMAM, the carrier was found to be
able to deliver carboplatin to the cancer cells, by enhancing the drug anticancer
efficiency. Moreover, the carboplatin loaded NGO carrier shows no significant
effect on the viability of hMSCs even at high concentration (100 µg.ml−1). On
neuroblastoma cells, the cell viability assay validated gelatin-NGO nanohybrids
as a useful nanocarrier for CP release and delivery, without obvious signs of
toxicity. The nano-sized NGO (200 nm and 300 nm) did not enable CP to kill
the cancer cells efficiently, whilst the CP loaded gelatin-NGO 100 nm resulted
in a synergistic activity through increasing the local concentration of CP inside
the cancer cells.
Zusammenfassung
Nanographit-Oxid-Partikel (NGO) wurden durch oxidative Abblätterung (Ex-
foliation) von Graphit hergestellt. Drei unterschiedliche Größen von NGO
(300 nm, 200 nm und 100 nm) wurden durch Ultraschallabscheidung und
Zuckergradienten-Zentrifugation getrennt. Generell besteht ein großes Interesse
an funktionalisiertem NGO als künstlichem Medikamenten-Transportmedium
auf Nanobasis, mit erhöhter Dispergierbarkeit und Stabilität in physiologischen
Medien, wie dem menschlichen Körper. In der vorliegenden Arbeit wurden die
NGO Partikel zum einen durch Polyamidoamid (PAMAM) der nullten Genera-
tion kovalent und zum anderen durch Gelatine nicht-kovalent funktionalisiert.
Spektroskopische Methoden wurden herangezogen um die chemischen
Zustände von NGO vor und nach der Funktionalisierung zu unterscheiden.
Röntgenphotoelektronenspektroskopiemessungen (XPS) zeigten eine deutliche
änderung der chemischen Zustände nach der Funktionalisierung, sowohl für den
kovalenten, als auch für den nicht-kovalenten Ansatz.
Ramanspektroskopiemessungen waren sehr aufschlussreich nach der Oxidation
von Graphit und der Funktionalisierung von NGO, in Abhängigkeit von den
Änderungen der Intensitätsverhältnisse der D, G und 2D Bänder zueinander.
Mit Hilfe von Fourier-Transformations-Infrarotspektrometrie-Messungen (FTIR)
konnte das Vorhandensein von funktionellen Gruppen, welche Sauerstoff bein-
halten, auf Graphen-Lagen nach der Oxidation von Graphit nachgewiesen
werden. Die FTIR-Studien sind hierbei komplementär zur den XPS-Studien
in denen ein deutlicher Rückgang des Sauerstoffanteils nach der Funktional-
isierung beobachtet wurde. Ultraviolett-Spektroskopie wurde genutzt um den
Ursprung der Bindungskapazität der mit Gelatine überzogenen NGO Partikel
zu untersuchen. Zusätzlich wurden die Rasterelektronenmikroskopie (SEM) und
Rasterkraftmikroskopie (AFM) herangezogen, um die Maße (Dicke und Breite)
der NGO Partikel zu bestimmen.
Das Nanohybrid-System (NGO-PAMAM und Gelatine NGO) wurden mit Car-
boplatin (CP) beladen. Das System ist vielversprechend im Hinblick auf Krebs-
bekämpfung von HeLa und Neuroblastoma Krebszellen.
Mesenchymal-Zellen wurden als Modell-Zellen verwendet. An HeLa-Zellen
wurden zytotoxische Effekte für NGO Partikel (Breite 200 nm und 300 nm) für
niedrige und hohe Konzentrationen beobachtet. Die NGO Ausgangsproben mit
einer Durchschnittsbreite von 100 nm zeigen keine signifikante Zytotoxizität
bei 50 µg.ml−1 und ein Niveau von 10% bei 100 µg.ml−1. Die mesenchymalen
Stammzellen zeigten eine Überlebensrate von weniger als 35% für jegliche
Größen. Nach der Funktionalisierung mit PAMAM was Trägersystem in der Lage
Carboplatin zu den Krebszellen zu liefern. Weiterhin zeigte der mit Carboplatin
beladene NGO-Träger keine signifikanten Effekte auf die Lebensdauer der
Mesenchymal-Zellen (hMSCs), selbst nicht bei hohen Konzentrationen 100
µg.ml−1.
An Neuroblastomazellen wurden Gel_NGO Nanohybride als nützliche,
nicht toxische Nanoträger für CP bestätigt. Das Nano-NGO (200 nm und 300
nm) konnte CP nicht in die Lage versetzen Krebszellen effizient zu vernichten,
während mit Gel_NGO (100 nm) eine synergetische Aktivität durch Erhöhung
der Konzentration von CP in den Krebszellen resultierte.
Motivation
In the past decade, the rapid development of graphene oxide nanohybrids has
brought many interesting insights and prospects to cancer cells diagnosis and
treatment. The first exploration of nanographene oxide in drug delivery and
cancer therapy was commenced at Stanford University in 2008, motivated by
the progress achieved by using carbon nanotubes for biological applications.
Since then, graphene and its derivatives were used extensively and exhibited
more exciting results compared to other nanostructured materials.
Graphene oxide (GO) particles possess many advantages for biological
purposes over other related sp2 carbon nanomaterials like carbon nanotubes
(CNTs). First, high solubility and stability in physiological media, CNTs for
instance require cutting and de-bundling process for better stability. Second,
no metallic catalysts required for producing graphene oxide particles, while the
remaining catalysts (impurities) during CNTs preparation induced cytotoxic
effect in cell culture investigation. Third, GO does not require surfactants for
dispersibility compering with CNTs, the surfactants being a cause of toxicity.
Fourth, extremely large surface area (2630 m2.g−1) and sp2 hybridized carbon
atoms, GO provides high effectively loading of aromatic drugs on both sides
of a single layer through π - π stacking, van der Waal forces, H – bonding, etc.
Five, remarkable biocompatibility of GO and facile functionalization thanks
to enrich oxygen groups have received increasing attention towards biomedical
applications. Many potential aspects have to be taken into account before
integrating GO in vitro or in vivo. For example, the size, shape, oxidation
methods, degree of oxidation and thickness of graphene oxide particles affect
the quality of functionalization, as well as the efficiency of drug molecules on
treated cells.
In summary, graphene oxide nanohybrids emerge as a functional tool for
drug loading and delivery, currently many challenges need to be elucidated by
effective collaborations crossing multiple disciplines including chemistry, physics,
biology and medicine.
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1
Introduction to
Graphene
In this chapter, a brief introduction on carbon allotropes, graphene, graphene
oxide and functionalized graphene oxide materials are elucidated. The toxicity
of carbon based nanomaterials, as well as the functionalized nanostructures
are extensively evaluated in this chapter. A short background about the drug
(Carboplatin) and the cell models used in this study are presented. Most sections
in this chapter are published as a review article in Journal of Nanoparticle
Research 1.
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Nicholas Ioannides, Barbara Trzebicka, Silke Hampel and Mark H. Rümmeli.
Graphene Oxide-Based Drug Delivery Vehicles: Functionalization, Characteriza-
tion and Cytotoxicity Evaluation. J. Nanopart. Res. (2013), 15, 2099.
2 1. Introduction to Graphene
1.1 Allotropes of carbon
Carbon, an element has four valence electrons in its outer shell, two are localized
in 2s and two are in the 2p shells, the mixing of 2s and 2p orbitals is generally
possible resulting in varied hybridization (sp, sp2 and sp3). The promotion of
an electron from 2s to 2p orbitals will generate four equivalent hybrid orbitals,
sp3 occurs when a carbon atom bonds to four groups and form four sigma (σ)
bonds, while sp2 has three attached groups formed three sigma bonds and the
remaining p orbital comes to form one pi (π) bond. Due to hybridization, pure
carbon is available in a large variety of allotropes, for instance diamond and
graphite represented as the only carbon allotropes known for a long period of
time.1
In 1985, Krotto et al. succeeded in synthesis of a spherical network
of equivalent sp2 hybridized carbon atoms in a shape of football called 0-
dimensional fullerene,2 it was reported as the first prepared allotrope of carbon
in a macroscopic scale. Afterward the family of synthesized carbon allotropes
dilated to include one-dimentional carbon nanotubes (CNT) in 1991,3 and lately
two-dimensional graphene (fig. 1.1). In graphite gallery, a multilayer and planar
sheets coalesce via van der Waals forces with a distance 0.34 nm, the layers
can be easily exfoliated by using simple technique called “scotch tape” to reach
incredibly one atom thick layer known as graphene, the experiment was initially
organized by Geim and Novoselov in 2004. As a result, graphene donates an
exciting physical and chemical properties in different applications.4
1.2 Graphene: history and properties
In 1930s, Landau and Peierls argued that the two dimensional crystals are not
exist due to thermodynamic instability, the theory suggested that the thermal
fluctuations in 2D crystal lattices lead to such displacement of atoms that
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equivalent the interatomic distances at any finite temperature, this suggestion
supported by experimental observations. Indeed, as the thickness of thin film
(number of layers) decreases the melting temperature drastically decreased and
they become unstable and start to decompose or segregate into islands at a
thickness typically tens of atomic layers.5 This theory was dominated until
2004 when the experiment realized 2D graphene crystal, it is consequently
defined as one atom thick of ordinary carbon atoms tightly packed into two
dimensional honeycomb crystal lattice. Noteworthy, the fascinating physical
and chemical properties of graphene enabled its used in many applications,
such as, nanoelectronics, sensors, nanomedicine, drug delivery, etc., have been
intensively pursued.
Figure 1.1: Synthetic allotropes of carbon. Reprinted with
permission from ref.6
4 1. Introduction to Graphene
In this thesis, the interesting property of graphene resides in its ability to
coordinate with other molecules via physisorption, van der Waals forces, H -
bonding, π - π stacking, etc. Water soluble derivative of graphene (graphene
oxide) motivates toward biological applications, owing to high surface area and
low side effects after modifications.
1.3 Methods for graphene production
There are four main methods for obtaining graphene: 1) mechanical exfoliation
or scotch tape of bulk graphite, 2) chemical vapor deposition (CVD), 3) epitaxial
growth of graphene films on silicon carbide (SiC) and 4) reduction of graphene
oxide.7–11 In the first method, the peeling-off monolayer graphene sheet has been
achieved by a simple method known as scotch tape method, and consequently
led to the Nobel-Prize-winning in physics for an exceptional breakthrough in
high quality graphene production.
In CVD method, the graphene monolayer deposited onto different sub-
strates, such as, Ni, Cu, Co or alloys. The carbon precursors (methylene,
ethylene, acetylene, etc.) and other gases such as nitrogen, argon and hydrogen
are gathered at elevated temperature up to 1000 ◦C in a proper chamber.
The reaction time, initial concentrations of gases and carbon precursors,
type of substrate and cooling rate should be controlled and optimized in order
to obtain few layers or even one layer of graphene.
1.4 Graphene oxide
The superiority of GO resides effectively in its chemical structure, which confers
an astonishing chemical versatility, high aspect ratio and extraordinary physical
properties. GO can be produced based on oxidation of graphite powder using
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of oxidizing agents in strong acidic medium, Brodie, 1859 and Hummers, 1958
are known as the major protocols for obtaining GO.
The presence of oxygen groups on pristine graphene basal plane and edges
makes it as an amenable for chemical functionalization, with organic compounds
or biological molecules in covalent and or non-covalent approaches under suitable
conditions.
1.4.1 Structure and properties
Fig. 1.2 shows the chemical structure of graphene and GO. Over the years,
considerable effort went toward understanding the structure of GO.
In GO, the carbon atoms covalently bonded to oxygen containing groups
are sp3 hybrids and can disrupt the sp2 conjugated system of graphene lattice
structure. sp3 hybridized regions are randomly distributed either in or out of the
basal plane of graphene sheets or at the edges.12–14 The properties of GO are
unreliable and depend on its synthesis methods, processing and experimental
conditions.15
Electrically, GO is considered an insulating material due to its widespread
saturated sp3 bonds, vacancies (missing carbon atoms) and negatively charged
density species bound to carbon. For these reasons, the energy gap increases
and makes GO nonconducting.16,17 Nevertheless, the structural and electronic
properties of GO can be modified via chemical and thermal treatments.18 The
optical properties also depend on the oxidation level of GO,19 the multiple layers
of GO change considerably the corresponding optical properties, for instance,
the refractive index of thermally reduced GO is higher than that in stacked
GO.
GO is highly soluble and disperses well in water and physiological media,
making it attractive for medical purposes after numerous modifications.
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Figure 1.2: Chemical structure of graphene and graphene oxide.
1.4.2 Methods for obtaining graphene oxide
The most common chemical routes for GO preparation arise from expandable
graphite by chemical exfoliation using various oxidizing agents, such as potas-
sium permanganate KMnO4 and potassium chlorate KClO3. These routs were
comprehensively covered in previous reviews13,20 and summarized in table 1.1.
The first procedures for GO were developed by Brodie (1859),21 Stauden-
maier (1898)22 and Hummers and Offeman (1958).23 Brodie treated graphite
with KClO3 and fuming nitric acid (HNO3). Staudenmaier improved Brodie’s
approach by slowly adding KClO3 over one week to a solution containing concen-
trated sulfuric acid (H2SO4), concentrated HNO3 (63%) and graphite. The mass
ratio of graphite to KClO3 was 1:10, the possibility of explosion and length of
time required are the main drawback of this approach. Hummers and Offeman
reported an alternative method, which is safer and also not time consuming.
In this protocol, a water-free mixture of concentrated H2SO4, sodium nitrate
(NaNO3) and KMnO4 are involved, the reaction was performed at 45 ◦C and
continued for approximately 2 h.
Minor modifications to the Hummers method were developed and still remain
in use.24
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Table 1.1: Methods for the oxidation of graphite to graphite oxide.
Brodie Staudenmaier Hummers Modified Hummers
year 1859 1898 1958 1999 2004
Oxidants KClO3, KClO3 (or NaNO3, pre-ox: K2S2O8, NaNO3,
HNO3 NaClO3), KMnO4, P2O5,H2SO4 KMnO4,
HNO3,H2SO4 H2SO4 ox: KMnO4,H2SO4 H2SO4
C:O ratio 2.1621 N/A22 2.2523 1.325 1.824
2.2826 1.8526 2.1726
Reaction 3-4 days21 1-2 days22 2 hours23 6h pre-ox+2h ox25 5 days24
time 10 hours26 10 days26 9 - 10 hours26
Intersheet 5.9526 6.2326 6.6726 6.925 8.324
spacing (A◦)
1.4.3 Functionalization of carbon: covalent and noncovalent
It is well known that carbon nanomaterials aggregate in cell culture media
(buffers) caused by the charge screen effect, therefore, surface modification is the
key to render the solubility and the biocompatibility of carbon nanomaterials
for biological systems. Depending on application purposes, two surface coating
regimes are developed, including covalent and noncovalent approaches, allowing
GO to be used in biological systems. Before surface functionalization, the size
distribution and individual separation of GO are essential for in vitro and in
vivo drug delivery.
Covalent functionalization, the covalent functionalization of
Nanoscaled carbon materials (CNMs) is preceded by an oxidation of the graphite
in acidic media with strong oxidizing agents, resulting in oxygen-rich groups.
As described above, the GO is highly oxidized by oxygen groups with C/O
ratio of 2:1. The presence of these functional groups allows various chemical
routes already known in chemistry to functionalize GO, for instance, covalent
functionalization of GO by sodium azide, reduction of azide functionalized GO
with LiAlH4 producing amino-functionalized GO and functionalization of GO
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with acylation, esterification and nucleophilic ring opening reaction.27 Fig. 1.3(a
and b) represents the covalent interaction of polyethylene glycol (PEG) and
PAMAM for 7-ethyl-10-hydroxycamptothecin (SN-38) and carboplatin drug
leading and delivery respectively.28
a b
Figure 1.3: Covalent functionalization of NGO. a, PEG functionalized NGO
for SN-38 loading, reprinted with permission from ref.29 b, PAMAM functionalized
NGO for carboplatin loading.
Noncovalent functionalization, the non-covalent functionalization with
different chemical substances is essential and considered to have less impact
on the structure and properties of graphene. The attachment of functional
groups to GO mostly occurs via π − π interaction, electrostatic binding, van der
Waals and H-bonding.30–32 For the first time, via non-covalent functionalization,
PEG-NGO was employed as a nanocarrier to load therapeutic anticancer drugs
and its cellular uptake was studied.29,33 Owing to their high conjugation system,
pristine graphene and GO possess the ability to bind with aromatic compounds
including cancer drugs, fluorescence molecule (fluorescein), catalytic hybrid and
combinations of molecules.
1.5 Carboplatin
Carboplatin, cisplatin and oxaliplatin are the three members of platinum based
therapeutic anticancer drug agents. These compounds have the ability to
bind the DNA molecules, forming a variety of structural adducts and induce
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apoptosis in cancer cells. The carboplatin or paraplatin-AQ (trade name) is a
chemotherapy drug used for killing some forms of cancer cells, such as ovarian,
neck, bladder, breast, etc., which shows less side effects compared to its analog
form cisplatin, in which the two chloride atoms are replaced by bidentate
dicarboxylate ligand (fig. 1.4). The use of any therapeutic agent against cancer
cells - in vitro or in vivo - is limited by its uptake promotion and cytotoxicity.
In the same context, carboplatin is superior to cisplatin,34 it was indicated
that larger dose of carboplatin is being clinically used to produce equivalent
toxicity to that of cisplatin, the presence of a stable bidentate dicarboxylate
chelate ring structure in carboplatin is responsible for reducing the reactivity
and cross-linking towards DNA, and producing less cytotoxicity when compared
to cisplatin. Thereby, it can be hydrolyzed in much slower rate compared to
reactive chloride ligand designated in cisplatin structure.35 Despite differences
in solubility in cell culture media (cisplatin less soluble), this property has no
effects at physiological concentrations.
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Figure 1.4: Chemical structure of cisplatin and carboplatin as platinum-
based chemotherapy agents.
1.5.1 Mechanism of action
Carboplatin and cisplatin have the same mechanism of action toward DNA
and RNA cross-linking formation as seen in fig. 1.5. The carboplatin forms
longer cross-linking with DNA strands, nevertheless the cross-linking of cisplatin
formed faster (6 - 8 hours after administration) than those of carboplatin (18
hours) due in part to the hydrolysis kinetics. Once inside the cancer cell,
the carboplatin ring structure is hydroxylated to form the active side, which
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efficiently bonds to DNA and RNA strands in order to functionally disrupt
these nucleic acids.34,35
Cisplatin
Carboplatin
Oxaliplatin
DN
A bases
Figure 1.5: Mechanism of DNA platinum based compounds interaction.
Reprinted with permission from ref.36
1.6 Toxicity assessment of graphene derivatives
Graphene, it has been developed to be a biocompatible platform for adhesion
and proliferation of murine fibroblast cells (L-929),37 neuroendocrine cells (PC-
12), oligodendroglia cells (OLC), osteoblasts (OBS)38 and mesenchymal stem
cells.28 Various cytotoxicity investigations have been evaluated on graphene,
GO and functionalized GO in different cell lines.39–41
Graphene oxide, a highly biocompatible material, thus, it inspirits the
proliferation and adhesion of kidney cells, OBS and human embryonic stem cells
(hESc).38,42 On the contrary, other studies showed GO nanosheets mixed to cell
culture media at 20 μg.ml−1 can produce 20% reduction in cell viability, whereas
50 μg.ml−1 GO induce 50% loss in cell viability, this result was attributed to
inhibitory effect due to the GO suspension.43 Wang et al. examined human
fibroblast cells (hFBc) with GO at different concentrations and found that
concentration dependent on cytotoxicity when the concentration exceed 50
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μg.ml−1.39 For the first time, the cyto- and geno-toxic effect of reduced GO
nanoparticles were investigated with mesenchymal stem cells,28 with the study
showing that the size and the concentration of GO are effective parameters on
the hMSCs cytotoxicity. Recently, in vivo cancer treatment using graphene as
nanocarrier has been performed in animal experiments,44,45 the results performed
that the toxicity of graphene oxide to mice depends on different factors, such
as, size, concentration, dosage, incubation time, etc.
Functionalized graphene oxide, as previously discussed, GO needs to
be functionalized in order to perfectly disperse in culture media, as well as being
compatible with tissue organisms. Indeed, GO revealed two types of functional-
ization (covalent and/or non-covalent) with small molecules or macromolecules,
depending on the chemical structure of materials used for GO modification.
Functionalized NGO with biocompatible materials such as PEG,29 dextran,46 chi-
tosan,47 pluronic,48 tween,42 low generation PAMAM,28 polyvinylpyrrolidone,49
gelatin,50,51 sulfonic acid groups52 and protein (fetal bovine serum-FBS),53 etc,
revealed high reduction in vitro and in vivo toxicity. In the same context, Zhang
et al. measured the cell viability percent of NGO-PEG vehicles as a function of
concentration,54 and the data showed that above 95% of mouse breast cancer
cell line (EMT6) remained viable even at high concentration up to 100 μg.ml−1,
which revealed that NGO-PEG has no cytotoxic effect to EMT6 cells after
24 h incubation. In other studies, gelatin-functionalized graphene nanosheets
exhibited very low cytotoxic effect against adenocarcinomic human alveolar
basal epithelial cells (A549), even at high concentration 300μg.ml−1. Surface
modification of GO with appropriate biocompatible materials increases the
uptake impact on various cell lines and retorts on the negative performance of
pristine graphene and GO via a number of mechanisms such as relative oxygen
species (ROS) and cell wall membrane damage.
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1.7 Toxicity assessment of other carbon nanomaterials
Several studies emphasized that numerous factors such as chemical composition,
size, shape, contaminants, concentration and cell types will influence the cellular
uptake and the cytotoxicity of carbon-based materials.33,55–59 To the best of our
knowledge, there are few experimental reports that compare the cytotoxicity
of carbon nanomaterials.40,60,61 Table 1.2 highlights the cytotoxicity evalua-
tion of carbon nanomaterials concerning the size, concentration and biological
systems.
Comparsion with CNTs, PEGylated NGO exhibited distinctive in vivo
behaviors such as reduced reticuloendothelial systems (RES) accumulation and
particularly improved tumor passive targeting effect.62 The unique 2D structure,
small size (10-50 nm) and biocompatibility played an important role to enhance
permeability and the retention effect of nanographene sheets (NGS) for high
tumor passive uptake. Carbon nanotubes in both forms, single- and multi-
wall CNT, are widely considered to be as speculate materials for biomedical
applications. The large length-to-diameter aspect ratio (more than 106; 1 mm
length and 1 nm diameter) with high surface area makes it amenable for high
molecular detection and recognition. Pristine CNTs are intrinsically insoluble
in water and biological media, i.e., they cannot be explored directly in drug and
bimolecular fields, thus, CNTs should be functionalized to render them soluble
and compatible in cell culture media. The toxicity of single- and multi-wall
CNTs is attributed to numerous factors, for instance, length to diameter ratio,
assay methods, functionalization, concentration, time of exposure and nature of
cells investigated.
Wörle-Knirsch et al. found that the toxicity of SWCNTs depends on the
preparation assay, the results showed that the viability of A549 decreased up
to 40 via Methylthiazol Tetrazolium (MTT) assay after addition of SWCNTs,
but no changes on viability by using 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-
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disulfophenyl)-2H-tetrazolium, monosodium salt(WST-1) assay method.63
Comparsion with nanoparticles, such as gold nanorods (AuNRs) sig-
nificantly explored as photothermal agents, the result showed that PEGylated
NGS emerged as comparable with PEGylated AuNRs in terms of administra-
tion routes (intravenous), injected doses (20 mg.kg−1), NIR laser densities (2
W.cm−2) and irradiation durations (5 min).64
Comparsion with fullerene, the first carbon nanomaterial investigated
toward biomedical applications due to it being the first to be discovered in
1985,65 and classified as an inorganic nanoparticle with wide availability due to
its small size (ca. 1 nm). Innate fullerene particles have very low dispersibility
in water and form negative charge aggregates with an average size of 160 nm.
Hence, -OH groups and other organic molecules are induced in fullerene in
order to activate its surface for better dispersibility in water and physiological
media,66,67 high dosages of fullerene particles, more than 70 mg.L−1 lead to cell
death after 24 h incubation, as the fullerene concentration and incubation time
increase, the cell mortality increases.67
From chemistry point of view, GO has conspicuous advantages in biological
applications over other carbon based nanomaterials, such as CNTs. First, high
water solubility without the cutting and de-bundling process required for CNTs.
Second, it has no or very law oxidative stress commencing from metallic catalyst
impurities, which induces CNT toxicity. Third, GO has excellent dispersion in
cell culture media which does not entail surfactants, the latter being an influence
of CNT - induced toxicity. Fourth, it has high surface area, which tolerates high
drug leading capacity via π - π interaction.68,69
14 1. Introduction to Graphene
Table 1.2: Toxicity evaluation of carbon nanomaterials
CNMs Size Concentration Biological Comments Ref
system
GO Below 200 nm 50 μg.ml−1 HeLa No cytotoxic effect even 70
at high concentration
GO LD: 350 nm, 0 - 20 μg.ml−1 PMØ, J774A.1 No significant difference 71
H: 3.9 nm LLC, MCF-7 in cytotoxicity between
LD: 2 μm HepG2, HUVEC 350 nm and 2 μm at different
H: 4.05 nm concentration.
GO 1429 ±89nm 20 - 100μg.ml−1 HUVECs Cell viability is 72
H: 1.038 nm concentration dependent
rGO LD = 3.8 ±0.4μm, hMSCs Cell destruction at 11 ±4nm. 71
LD = 11 ±4nm 3.8 ±0.4μm has cytotoxic
effect only at high
concentration of 100 mg.ml−1.
GO - CS GO > 1000 nm, 0.1 - 100 mg.ml−1 HepG2, HeLa GO - CS has no obvious 73
0.8 - 1.2 nm (GO - CS) cytotoxicity,
thickness. 80% Cell viability
GO-CS < 500 nm,
4 - 5nm
GO-PEG 5 - 50 nm 0.1 - 100 mg.ml−1 HCT-116, (72 h) NGO - PEG exhibited no obvious 33
toxicity
SWCNTs 1 nm (φ) 3.8μg.ml−1 macrophage cells The macrophages consume high 74
1000 nm (L) quantity of SWCNT without
showing toxic effects.
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Functionalized 1 - 5 nm (φ) 50 μg.ml−1 HL-60, 3T3, CHO No toxicity observed for 75
SWCNTs 0.1 - 1 μm(L) SWCNTs and functionalized
SWCNTs by endocytosis.
SWCNTs, SWCNT: 0 - 226μg.ml−1 Guinea pig 76
MWCNT, 1.4 nm (φ) alveolar
C60, 1000 nm (L) macrophage
MWCNT: Cytotoxicity of MWCNTs
10 - 20 nm (φ) was lower than SWCNTs
0.5 - 40 μm (L)
SWCNTs 2 nm (φ) 0 - 100 μg.ml−1 HDF Cell survival rate: 77
500 nm (L) MWCNTs>CB>AC>SWCNTs
MWCNTS 50 nm (φ)
5000 nm (L)
Carbon black 200 nm (r)
Activated C 25 nm (r)
SWCNTs 8 nm (φ) 5-100μg.ml−1 PMEF SWCNTs revealed moderately 61
L < 5000 nm cytotoxic effect than metal
Carbon black oxides, but persuaded more
SiO2 10 - 20 nm (φ) DNA damage.
ZnO
SWCNTs 4 nm (φ) 200 - 400 μg.ml−1 In vivo SWCNTs are less toxic 78
0.5 - 100 μm (L) than MWCNTs
MWCNTs 15 nm (φ)
0.5 - 200 μm (L)
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List of abbreviations mentioned in table 1.2:
LLC Lewis lung carcinoma
MCF-7 Breast cancer cells
HepG2 Human liver carcinoma cells
HUVEG Human umbilical vein endothelial cells
hMSC Human mesenchymal stem cells
HCT-116 Human colon cancer cells
PMØ Peritoneal macrophage
J774A.1 Mus musculus, mouse
HL-60 Human promyelocytic leukemia cells
3T3 Mouse embryonic fibroblast cells
CHO Chinese hamster ovary cells
HDF Human dermal fibroblast
PMEF Primary mouse embryonic fibroblast
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1.8 Nanoscaled drug delivery vehicles
In vitro tests, various aromatic drugs have been loaded onto function-
alized NGO, such as doxorubicin (DOX) and water insoluble 7-ethyl-10-
hydroxycamptothecin (SN-38). DOX and SN-38 are the first two drug molecules
loaded on PEGylated nanographene oxide (NGO-PEG) as a vehicles for drug
delivery. DOX loading onto NGO-PEG achieved by simple mixing with NGO-
PEG solution under controlled pH overnight via physisorption π - π stacking.
NGO-PEG-Rituxan/DOX with lymphoma cell (Raji-B) investigated in vitro,
the result revealed that DOX delivery into Raji B - cells enhanced in NGO-
PEG-Rituxan/DOX comparing with free DOX and NGO-PEG/DOX as well.
Thiolated Rituxan (marker protein (CD20) + antibody) conjugated to the
amine groups onto NGO-PEG is used for selective killing of cancer cells.29
Water insoluble molecule SN-38 loaded NGO-PEG via π − π stacking
revealed excellent solubility in the biological environment,33 NGO-PEG/SN38
exhibited high influence to kill cancer cells in vitro with a human colon cancer
cell line (HCT-16). Folic acid loaded NGO with the two anticancer therapeutic
drugs (DOX and irinotecan (CPT-11)) showed specific targeting to human
breast cancer cells (MCF-7), as well as high cytotoxicity compared to unmodified
NGO loaded with DOX or CPT.52 Methotrexate (MTX) loaded onto gelatin
functionalized graphene nanoparticles (GNP) showed better release at low pH
than neutral conditions, GNP - gelatin/MTX system exhibited lower cytotoxic
effect with adenocarcinomic human alveolar basal epithelial cells (A549) in
comparison with free MTX at the same concentration.51
In vivo tests, the in vivo therapeutic efficacy of NGO-PEG/DOX was
demonstrated through combination of photothermal treatment and chemother-
apy, in this study,54 four mice groups were treated with buffer, DOX, NGO-PEG
and NGO-PEG/DOX. The tumor region of NGO-PEG and NGO-PEG/DOX
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irradiated by NIR light after 24 h of injection. Free DOX exposed rapid growth
of tumor volume as a result of insufficient dosage to reduce it. NGO-PEG group
showed reduction in the tumor volume after a few days of injection, and then
follows its growth to reach the size of DOX group. NGO-PEG/DOX showed
considerable trend with size reduction of tumor volume along a period of 30 days,
this group demonstrated as a powerful vehicle for combined chemo-photothermal
therapy of cancer in vivo. Furthermore, the result revealed no weight loss was
perceived, indicating that the toxicity of materials was not severed.
On the other hand, Yang et al. reported for the first time the behavior of
nanographene sheets in vivo by using PEG coating via a fluorescent labeling
method, PEG-functionalized GO was labeled with the fluorescent cyanine-7
(Cy7) dye for in vivo investigations, the majority of Cy7 dye molecules are
covalently bonded to NGO-PEG via an amide bond formation. Three tumor
models (4T1 tumor bearing Balb/c mice, KB and U87MG tumor bearing nude
mice) were demonstrated with different time points after intravenously injected
by NGO-PEG-Cy7 and subsequently imaged.
The concentration of NGO-PEG-Cy7 versus time was measured and the
blood circulation half-life was observed approximately at 1.5 h. NGO-PEG-
Cy7 existed in different tumor models over time, NGO-PEG exhibiting an
excellent in vivo tumor near-infrared (NIR) photothermal therapy without
obvious toxicity to the treated mice. Neither death nor noteworthy body weight
drop was observed in the NGO-PEG plus laser-treated materials after 40 days
of photothermal therapy, the major organs of treated mice were collected for
histology analysis, the results exhibited no noticeable signal of organ distortion,
suggesting the assure of using PEGylated NGS for in vivo applications.56
Table 1.3 summarizes the cytotoxicity and the cellular uptake in vitro and in
vivo for various therapeutic systems.
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Table 1.3: In vitro and in vivo toxicity evaluation of therapeutic nanomaterial systems.
Therapeutic Concentration Biological Comments Ref
systems system
GO based therapeutic systems
NGO - PEG - 2, 10 mole.L−1 Raji and High selectivity at [DOX] = 29
Rituxan/DOX In terms of CEM cells 10 mol/L.
DOX Rituxan improved doxorubicin
delivery into Raji B-cells.
Less toxic than free DOX
NGO - PEG/ 1 mg.ml−1 HCT - 116 High cancer killing potency 33
SN 38 in terms of in comparison with free SN 38
SN 38 molecules in organic solvents.
GO - Pluronic 100 wt% MCF-7 and High drug loading capacity. 79
(F38)/EA (GO - F38) HT-29 EA loaded onto functionalized
GO has less cytotoxic effect
GO - Tween 80 122 wt% than free EA.
(T80)/EA (GO - T80)
GO - Maltodextrin 114%
(MD)/EA (GO - MD)
GO - CS - CPT 10 μM HepG2 No obvious toxcity measured 73
CS: Chitosan HeLa cells for GO - CS.
CPT: Capto- GO - CS/CPT possessed higher
thecin cytotoxic effect than free CPT
GO - FA/Ce6 2:1 (wt/wt) MGC-803 GO FA is non-toxic. 49
(chlorine e6) 1:1 (wt/wt) 2:1 ratio revealed no dark
(GO-FA):Ce6 toxicity and more than 80% of
cell viability.
1:1 ratio revealed cell
viability less than 50%.
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Toxicity is concentration
dependent.
NGS - PEG/ 20 mg.kg−1 In vivo PEGylated NGS largely 45
125I gatheredin the
reticuloendothelial system.
No toxic effect at 20 mg/kg
to the treated mice in
a period of 3 months.
CNT based therapeutic systems
CNT - CP 20% DU145,PC-3, No toxic effect observed for 80
CNF - CP 14% A498, EJ28 unloaded CNTs at 100 μg/ml.
No noteworthy toxicity
observed for unloaded CNFs
at 100 μg/ml.
CNT - CP showed low cancer
cell growth than free CP.
DOX - FA - 300 wt% HeLa cells DOX – FA – CHI/ALG – SWCNTs 81
CHI/ALG - are highly selective system
SWCNT and not cytotoxic.
DOX - PL - 270 mg.l−1 In vivo The SWCNT - DOX (5 mg/kg) 82
PEG - SWCNT of DOX. (SCID mice) exposed greater inhibition
of tumor growth than free DOX.
Mice treated with SWCNT - DOX
possessed stable weight and
no mortalities compared with
free DOX.
SWCNT-cisplatin 100 μg.ml−1 PC3 Free cisplatin and SWCNT - 83
DU 145 Cisplatin have the same effect
on PC3, but less effective DU145.
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Fullerene based therapeutic systems
C60 – PEI – 200 wt% PC3 C60 – PEI – FA has no obvious 84
FA/DTX In vivo toxicity to PC3. The system has
Murine S 180 higher inhibition efficiency
than free DTX.
C60 – PEI – FA/DTX is more
effective than free DTX and C60
- PEI - FA in vivo.
Nano - C60 0.24-2 ppb HepG2, Nano-C60 has cytotoxic effect 85
(water soluble) 400 ppb HDF, to tested cell lines after
NHA, 48 h exposure
C60(OH)24 100 μg.l−1 HDF 86
HepG2 cells
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List of abbreviations mentioned in table 1.3:
Raji-B B-lymphoma cells
CEM Human lymphoblasts
DOX Doxorubicin
HCT-116 Colorectal carcinoma
SN-38 7-ethyl-10-hydroxycamptothecin
PEG Polyethylene glycol
MCF-7 Human breast cancer cells
HT-29 Human colorectal adenocarcinoma cells
FA Folic acid
HepG2 Human liver carcinoma
MGC-803 Human gastric cancer cells
Ce6 Chlorin e6
EA Ellagic acid
DU145 Human prostate cancer cells
PC-5 Neuronal cells
A498 Homo sapiens carcinoma cells
EJ28 Human bladder cancer cells
PC-3 Human prostate cancer cells
SCID
Severe combined immunodeficiency
(mice)
PEI Polyethylenimine
DTX Docetaxel
HDF Normal human fibroblasts
NHA Normal human astrocytes
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1.9 Biological studies
The difference between normal and abnormal cells is profound, not only because
of their shape and behavior but also the drastic difference in life expectancy. In
culture media, the cancer cells still survive forever, conversely the normal cells
such as mesenchymal stem cells die after 50 generations.
In this work, HeLa and neuroblastoma cell lines are used as a model for
studying the potency of carboplatin and carboplatin loaded nanohybrids in pro-
hibiting metabolic activity. Mesenchymal stem cells are used for biocompatibility
assays.
1.9.1 Mesenchymal stem cells
The human mesenchymal stem cells are usually found in bone marrow and
adipose tissue, they considered as adult or somatic cells, as well as a good model
of non-malignant multipotent stem cells. They have generated a massive interest
in medical purposes because of their ability to self-renew and differentiate readily
into variable cell types. Consequently they are rare cells and must be grown to
obtain adequate quantity for research and therapeutic applications.87
Recently, many reports have been developed to investigate the uptake and
cytotoxicity of graphene nanoparticles onto hMSCs, as an important model
for biocompatibility assays.28,55,88–90 The first report,89 Akhavan et al. has
investigated the size dependent cyto- and geno- toxicity of graphene oxide
and reduced graphene oxide onto hMSCs, the results showed the effect of
nanoparticles concentration and incubation time through monitoring viability.
In conclusion, hMSCs are actively proliferated and repetitively expandable
stem cells that could be used in vitro to study the uptake and cytotoxicity of
nanographene oxide particles in contrast to other primary stem cells.91
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1.9.2 HeLa cancer cells
The most common immortal cancer cell lines model known worldwide in biologi-
cal research. It was derived from a lady in 1951 called Henrietta Lacks, she died
of her cervical cancer eight months later and associated with her name (HeLa).
These cells indeed were the first cell lines survive and grow out of human body,
and can divide to unlimited times under suitable conditions.92 HeLa cells were
chosen in order to study the effects of NGO samples on cancer cells through
anticancer activity measurements.
1.9.3 Neuroblastoma cancer cells
A tumor of the childhood, represents approximately 9% of all cancers infect
children world-wide. It categorized as the most common extracranial solid
tumor in infants and existing as diffuse growth of undifferentiated neuroblastic
cells. Typically, the tumor starts from adrenal gland and ganglion chain and
often displays the ability to affect more than organ or tissue of neural crest
cells.
Park et al. studied the effect of graphene on growth of neuroblastoma
cells, the fluorescence data demonstrated that the presence of graphene did
not influence cell morphology, thereby these findings candidate graphene for
biological applications.93
The neuroblastoma cell line especially derived from human brain tumor
represents a good model to evaluate the cellular uptake and anticancer activity
of carboplatin and carboplatin loaded nanohybrids on tumor cells. This study
is useful to understand the effect of nanoparticles size, reactive oxygen species
and optimum concentrations prior in vivo investigation.
2
Materials and Methods
The procedures of nanographene oxide, functionalization (covalent and noncova-
lent) and carboplatin loading are shown in this chapter. The characterization
methods used throughout this thesis are discussed concisely.
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2.1 Synthesis of nanographene oxide particles (NGO)
2.1.1 Preparation of graphite oxide materials
Graphite oxide was produced from natural graphite (99.99%, -200 mesh, Alfa
Aesar) based on modified hummers method.12,28 Briefly, 1.0 g graphite (Gr) was
ground with 50.0 g of NaCl for 10 min in order to exfoliate the graphite flakes
(de-agglomeration), as well as reduce their dimensions. The ground graphite
(Gnd Gr) was dissolved in warm distilled water and collected using a 450 nm
porous TEFLON filter paper by suction filtration. The filtered graphite was
mixed in 23 ml of H2SO4 (95%, VWR) overnight. Thereafter, the mixture was
placed in an ice bath to ensure that the temperature remained below 10 ◦C.
Subsequently, 3.0 g KMnO4 (99%, VWR) was added gradually over 3 hours
with constant stirring.
After complete addition of KMnO4, the mixture was sonicated for 3 hours
and continuously stirred for 30 min at 35 ◦C and 45 min at 50 ◦C, respectively.
46.0 ml distilled water was added to the mixture and kept with stirring at 98 -
105 ◦C for 45 min. The mixture was cooled down to room temperature (RT) and
stirred with the addition of 140.0 ml distilled H2O and 10.0 ml of 30% hydrogen
peroxide H2O2 (30%, Sigma-aldrich). The collected samples were filtered and
washed five times with HCl (5%, Sigma-aldrich) and distilled water to remove
any reaction by-products.
2.1.2 Sonication of graphite oxide for size reduction
Horn - tipped ultrasonic probe (BANDELIN ultrasonic, max. power of 25 - 60%)
under optimized conditions was used to crack and reduce the dimensions of
exfoliated graphene oxide particles.28,47,94 The concentration of GO, sonication
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time and power are considered as controlled conditions for obtaining nano-scaled
GO particles in water.
2.1.3 Centrifugation of NGO particles in sucrose solutions
Sucrose solutions were prepared with different viscosity to separate the sonicated
GO sheets according to their dimensions.28,95,96 Sucrose is a low cost material
and environmentally friendly, since it is selected for NGO size separation.
Typically, 20 - 60% sucrose solutions were prepared in distilled water, and
the layers of sucrose (with increasing density) were dropped into the bottom
of the centrifuge tube (335 ml each). On the top of multilayer water sucrose
solutions, 335 ml NGO in water suspension was layered prior to centrifugation
(BECKMAN COULTER, Allegra 64 R centrifuge) under typical centrifugation
conditions (5880 g for 5 min). Three different zones along the centrifuge tube
were obtained (washed sufficiently from sucrose) and separated as three sizes
for NGO functionalization and carboplatin loading.
2.2 Functionalization of NGO particles
2.2.1 Covalent functionalization of NGO by PAMAM dendrimer
The PAMAM - G0 dendrimer has four amine NH2 terminated groups.15,28,97–100
20 μL of a PAMAM solution in methanol (20%, wt/wt) was added to a solution
of NGO (1 mg.ml−1). The mixture was continuously stirred for 2 hours at
RT. The PAMAM functionalized NGO was collected, washed thoroughly with
distilled water and collected after centrifugation at (5880 g for 2 min) to remove
unbound PAMAM and methanol. The collected material was then left to dry
overnight below a temperature of 35 ◦C.28 The resultant material labeled as
NGO - PAMAM.
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2.2.2 Noncovalent functionalization of NGO by gelatin
20 μL of gelatin was added to a solution of NGO (1 mg.ml−1), the mixture was
continuously stirred for 2 hours at RT. The resultant was collected, washed
thoroughly with distilled water and collected after centrifugation at 5880 g for
2 min to remove unbound gelatin. The collected material, labeled Gel_NGO,
was then left to dry overnight below a temperature 35 ◦C.
2.3 Carboplatin loading
2.3.1 Preparation of CP loaded pristine NGO particles
Carboplatin stock solution (10 mg.ml−1, chemical formula C6H12N2O4Pt) was
purchased from Hospira Inc. USA. In separate experiments, 20 μL of carboplatin
was mixed with 1 mg.ml−1 NGO 100 nm, 200 nm and 300 nm with stirring for
2 hours at RT. Thereafter, the products labeled CP@NGO, collected and dried
under a vacuum at RT.
2.3.2 Preparation of CP loaded PAMAM and gelatin
20 μL of CP stock solution was added to a solution of 1 mg.ml−1 PAMAM. The
mixture was continuously stirred for 2 hours at RT. The resultant was collected,
washed thoroughly with distilled water and collected after centrifugation at
5880 g for 2 min to remove unbound PAMAM molecules.
The collected material labeled CP@PAMAM and left to dry overnight
below a temperature 35 ◦C. The same procedure was used for CP@gelatin by
using native gelatin as loading material.
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2.3.3 Preparation of CP loaded nanohybrid materials
In separate experiments, 20 μL of carboplatin was mixed with 1 mg.ml−1
NGO-PAMAM and stirred at RT for 2 hours. Thereafter, the products labeled
CP@NGO-PAMAM, were collected and dried under vacuum at RT.
The same procedure was used for the preparation of the CP@Gel_NGO
nanohybrids and stored under vacuum at RT.
2.4 Cell culture
The human cervical carcinoma cell line (HeLa) obtained from American type
culture collection (ATCC, Rockville, Maryland) and human neuroblastoma
cell line (IMR-32) obtained from Lonza were grown in a complete cell culture
medium for investigation of CP@NGO-PAMAM and CP@Gel_NGO nanohy-
brids respectively.28 The cell culture medium consisting of DMEM (Dulbecco’s
Modified Eagle Medium) supplemented with 2 mM L-glutamine, 100 IU mL−1
penicillin, 100 mg.mL−1 streptomycin and 10% heat - inactivated fetal bovine
serum (Gibco, Invitrogen).101,102 The cell culture was maintained at 37 ◦C in a
saturated humidity atmosphere of 95% air and 5% CO2.
In order to test effects of NGO and NGO derivatives, a modified culture
medium was prepared by mixing the nanocomposite solution with the complete
culture medium, while the complete culture medium served as the control sample.
Human mesenchymal stem cells, which are primary and non-malignant cells
obtained from Lonza were grown in the same culture medium and introduced
as healthy Cells.
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2.5 Viability assay
WST - 8 (2 - (2 - methoxy - 4 nitrophenyl) - 3 (4 - nitrophenyl) - 5 (2, 4 -
disulfophenyl) - 2 H - tetrazolium, monosodium salt) cell proliferation kit and
Alamar blue reagent were used to evaluate the cell viability for CP@PAMAM-
NGO and CP@Gel_NGO nanohybrids respectively.
HeLa, neuroblastoma cancer cells and hMSCs were cultured in DMEM
supplemented with 2 mM L-glutamine, 100 IU mL−1 penicillin, 100 mg.mL−1
streptomycin and 10% heat inactivated fetal bovine serum (FBS). Cells are
expanded in Petri dishes and maintained at 37 ◦C in a saturated humidity
atmosphere containing 95% air and 5% CO2. Thereafter the cells were plated
in 96 - well plates (25x103 cells per well) and incubated for 24 hours.
The modified medium containing the nanocomposites was introduced
separately to cells at different test concentrations and incubated for another 24
hours.
The cells cultured with the regular culture medium were tested as the control.
2.5.1 WST - 8 viability assay
A fresh media containing 10% of a WST-8 solution were added to each well and
incubated for an additional 2 hours at 37 ◦C.
The assay is based on the cellular dehydrogenase reduction of WST-8 to
an orange formazan dye which dissolves directly in a tissue culture medium, the
amount of formazan produced is directly proportional to the number of living
cells, the absorbance was recorded on a Versamax microplate reader (Molecular
Devices, Sunnyvale, CA) at a wavelength of 450 nm with the background
subtracted at 650 nm.28,101,102
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2.5.2 Alamar blue assay
To determine the viability of cells exposed to NGO particles, Gel_NGO nanohy-
brids and CP@Gel_NGO, an Alamar Blue (AB) assay has been utilized. The
active ingredient of AB dye is resazurin that is blue in color, soluble, nontoxic,
virtually non-fluorescent and undergoes colorimetric change in response to cellu-
lar metabolic activity. The reduced compound is resorufin, pink in color and
highly fluorescent.
The viable cells metabolize the AB dye and convert resazurin to resorufin,
thereby producing an increase in the fluorescence intensity as determined by
Versamax microplate reader (Molecular Devices, Sunnyvale, CA) at a wavelength
of 450 nm with the background subtracted at 650 nm, the absorbance intensity
is proportional to the number of living cells.
Indeed, the damage or non-viable cells have lower metabolic activity and thus
generate weak absorbance than healthy cells.103,104
The viability was measured as follows:
Percent viability = (experimental value/control value) x 100%.
Test media were assayed 3 times.
2.6 Statistical analysis
For the cell viability assays, three experiments were carried out and quadrupli-
cated, the statistical values were expressed as means and the standard deviation
was taken as the error. The statistical significance was assessed by one-way
analysis of the variance followed by a post-hoc comparison test (Tukey). The
significance was set at p < 0.01.
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2.7 Morphology and structure characterization
In this thesis, a variety of characterization techniques have been used to under-
stand the structure and properties of GO. These techniques are classified into
spectroscopic and microscopic approaches. The spectroscopic approaches are
used to identify the chemical structure of GO, and include Raman, FTIR and
XPS. Microscopic tools (AFM and SEM) are used to map out the structure of
GO at various heights and lateral dimensions.
2.7.1 Spectroscopic approaches
Raman spectroscopy, a probe of order and disorder in the carbon skeleton
of sp2 and sp3 hybridized carbon-based materials.
Graphite material (multiple graphene sheets) has three dominant Raman features
at 1580 cm−1 (G band), 1,350 cm−1 (D band) and 2,700 cm−1 (2D band), the G
mode corresponds to planar vibrations of carbon atoms and is present in most
graphite-like materials, the D mode is related to the structural defects and is
present in all graphite-like carbon materials.
In GO, the G band is wider and shifted to a lower frequency region ca.
1,590 cm−1, the D mode intensity increases and probably becomes higher than
the G mode due to the structural disorder in the sp3 pattern induced by oxygen
containing groups on the carbon basal plane or at the edges.
On the other hand, the 2D mode reduces and becomes wider with respect to
the D and G bands.105–107
The Raman spectra were recorded on a Thermo Scientific, DXR Smart
Raman with an excitation laser wavelength of 532 nm. The samples were
deposited on silicon substrate.
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Fourier transform infrared spectroscopy (FTIR), an infrared spec-
troscopy yielding complementary information to those provided by Raman
spectroscopy. The mid IR region contains the most useful vibrational frequen-
cies of various oxygen groups. Consequently, the IR spectrum is frequently used
in order to identify the presence or absence of specific functional groups in a
molecule.
In the case of GO, the most characteristic peaks are the broad peak of
hydroxyl group (-OH) at 3,430 cm−1, the peak at 1,720 cm−1 corresponding to
carbonyl group (C=O), 1,570 cm−1 representing the skeletal vibrations of sp2
carbon atoms, 1,225 cm−1 and ca. 1,100 cm−1 referring to stretching vibrations
of COOH and C-O-C, respectively.70,108,109 The FTIR spectra were recorded
on a Bruker IFS 113 spectrometer using the KBr disk method. The spectra of
NGO samples were recorded between 4,000 and 800 cm−1, each spectrum was
measured by averaging 256 scans recorded at a resolution of 2 cm−1.
The spectra of PAMAM, CP and CP@PAMAM thin films were recorded
using a FTIR (IFS/66v/S, BRUKER Optic, GmbH, Karlsruhe, Germany)
spectrometer supplied with diamond attenuated - total - reflectance - (ATR) -
crystal (RESULTEC, Illerkirchberg, Germany).
X-ray photoelectron spectroscopy (XPS), known also as electron
spectroscopy for chemical analysis (ESCA), a beam of X-rays in ultra-high vac-
uum (UHV) conditions, forcing the core electrons to be excited into unoccupied
atomic/molecular orbitals above the Fermi level. Simultaneously, the kinetic
energy in addition to the number of electrons that escape from the top few
nanometers of the material being analyzed is measured.
The XPS provides insight into the identity of the functional groups distributed
onto the surface which modulate the carbon nanomaterial’s properties.
In GO, XPS further unambiguously exhibits the carbon and oxygen bonds (C1s)
in their various forms; C-C (sp2 or sp3), C-OH, C-O-C, C=O and C=OOH.
34 2. Materials and Methods
Information provided by O1s spectra is complement with the C1s signals due to
lower kinetic energy than those of C1s. XPS provides information about the
identity of different kinds of metal ions like Cu, Ni, Co, Cu, Ag, Mg, Pt, etc.,
as well as information on the valences and the ratio of these metals.106,109–111
The XPS measurements were carried out in an ultrahigh vacuum sys-
tem (<10−9 mbar) equipped with a hemispherical electron analyzer SPECS
PHOIBOS 100. Photo-electrons in all XPS measurements were excited with
non-monochromatic Mg Kα (1253.6 eV) radiation and analyzed with a constant
pass energy of 15 eV. The X-ray source was run at a power of 300 watts.
2.7.2 Microscopic approaches
Scanning electron microscopy (SEM), a type of electron microscope
which images a sample by raster scanning it with a focused beam of high-
energy electrons, it is one of the most frequently used techniques in sample
characterization, due to its good resolution, ease of applicability, large depth of
focus and high magnification.
In a typical setup, an electron gun emits a high-energy electron beam in
a high vacuum chamber, which later passes through a series of focusing and
accelerating magnetic lenses, the high kinetic energy carried by the accelerated
electrons, is dissipated as a variety of signals produced by electron–sample
interactions when the incident electrons are decelerated in the solid sample,
including, in addition to many, the secondary electrons.
The generated signals are then drawn to the secondary electron detector which is
highly positively charged and guided through the Faraday cage to the collection
target, finally, they are converted into 2D gray scale images.
SEM is a versatile method used to gain information on the graphene and
GO domains like size, shape and nucleation density. It has also, recently, been
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used to study monolayer graphene onto different surfaces.112,113
SEM images were obtained using a FEI, NOVA NanoSEM 200 with an acceler-
ation voltage of 15 kV.
Atomic Force Microscopy (AFM), a high-resolution type of scanning
probe microscopy. It is a method to visualize the surface topology of materials
in three-dimensional (3D) detail down to the nanometer scale.113,114
AFM reveals the thickness of graphene and GO sheets, as well as the
number of layers.7 Moreover, it can show the distance between two graphene or
GO layers which is essential to distinguish between them. AFM uses a laser
beam detection system in order to control the piezoelectric element movements,
where the laser is reflected from the back of the deflected cantilever onto a
position-sensitive detector.
AFM works in three main modes: tapping mode, contact mode and non-
contact mode AFM.114 Tapping mode is frequently used in characterizing GO as
it allows high resolution imaging without inducing destructive frictional forces
onto the sample under investigation.
AFM images of well-defined NGO sizes and modified surfaces were acquired
using Digital Instruments Veeco, NanoScope IIIa, operating in the tapping
mode.
The images were analyzed using WSxM software designed by Nanotech Elec-
tronica (Madrid, Spain).115

3
Results and Discussion
This chapter is divided into three main sections; section 3.1 explains the
characterization of GO materials, as well as the optimized conditions for size
controlled and reduction. Section 3.2 elucidates the covalent functionalization
of NGO particles by using PAMAM as biocompatible material, the loaded and
unloaded nanohybrid systems with carboplatin were investigated in vitro with
HeLa cancer cells and mesenchymal stem cells, the results of this section have
been published in J. Mater. Chem. B 1. The noncovalent interaction between
NGO particles and gelatin is discussed in section 3.3, the biological systems
used for this study are the neuroblastoma cancer cells and mesenchymal stem
cells, the result of this part has been accepted for publication in Pharm. Res. 2.
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3.1 Size-controlled synthesis of nanographene oxide
3.1.1 Characterization of graphene oxide materials
The GO materials were carried out from graphite by using oxidation reaction.
Fig. 3.1 represents step by step the preparation reaction of GO, firstly, graphite
flakes ground with NaCl salt in order to de-agglomerate graphite gallery and
reduce its dimensions (lateral width and height).
Intercalation of concentrated sulfuric acid molecules (H2SO4) in graphite pro-
duced more expansion due to the weak interaction between graphite flakes and
no change on the lateral width observed (fig. 3.2a), as well as the acidic medium
is necessary for starting the oxidation reaction.
In step 1, adding KMnO4 to intercalated graphite (the temperature should
be below 5 ◦C) leads to the appearance of oxygen atoms as functional groups
distributed on the basal plane of graphene layers, as well as distort the hexagonal
sp2 - sp2 regime.
The thermal treatment in two intervals (step 2 and 3) yields more oxygen
groups due to rapid kinetics.116
Later in step 4, H2O2 solution was added to terminate the oxidation process
and the color changes to brown indicating a high level of oxidation (see the
inset photography in fig. 3.2a). After multiple washings, as prepared graphite
oxide was left in oven below 35 ◦C for drying.
An elemental micro-analysis (EXD (Energy-Dispersive X-ray analysis));
revealed the presence of carbon and oxygen atoms without contamination (fig.
3.2b).
The structure of graphite, ground-graphite (Gnd Gr), intercalated-graphite
(IG) and GO samples (four steps) were systematically studied using Raman and
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FTIR spectroscopy.
It is well known that the Raman spectrum of pristine graphite revealed
three characteristic bands at 1340 cm−1 (D), 1570 cm−1 (G) and 2700 cm−1 (2D)
as shown in fig. 3.2c, the spectra were normalized with respect to the G-band,
the D-band is indicative of structural disorder, this is seen to increase relative
to the G-band for the GO samples due to the increased structural disorder that
occurs through oxygen groups distribution.
The intensity ratios of D- to G-bands (ID/IG) increased from ca. 0.2 for
graphite to ca. 0.75 GO with addition of the oxidizing agent (KMnO4). The
G-band position shifts to higher frequencies from 1570 to 1598 cm−1 linearly
with reaction steps as does the full width at half maximum (FWHM). This
result indicating that a higher degree of oxidation depends on the reaction
conditions. All these changes are concomitant of oxidation.117–119
Changes between the starting graphite and GO samples in the FTIR
spectra can also be observed (fig. 3.2d). The FTIR spectrum of the pristine
graphite shows weak features in the mid IR region indicating little to no oxygen
groups being present as expected.120
The GO samples are shown to contain a variety of oxygen rich groups
normalized with respect to CH2 vibrational band appeared at ca. 2730 cm−1.
These include the hydroxyl (-OH), carbonyl (C=O) and epoxy (C-O-C) groups
at 3415, 1700-1730 and 1078 cm−1, respectively. The peaks from 1425 to 1225
cm−1 can be ascribed to COOH groups.109 The absorption band at 1575 cm−1
is attributed to the sp2-skeletal vibration of graphene sheets.109,121
Further chemical treatment of GO (from step 1 to step 4) brings further
successive increase in the oxygen contents.13 Throughout oxidation reaction,
the dimensions of GO particles remain relatively stable for both lateral width
and thickness as shown in panel (a) fig. 3.2.
SEM and AFM images of graphite and GO are presented in fig. 3.3.
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Figure 3.1: Schematic representation for graphene oxide (GO) production.
ba
c d
Figure 3.2: Statistical and spectroscopic analysis of graphite and graphite
oxide samples. a, Lateral width (μm) and height (nm) distribution of graphite and
GO samples, the inset photography is GO solution (2 mg.ml−1). b, EDX micro-analysis
of as prepared graphite oxide, the inset image is graphite oxide on filter paper. c and
d, Raman and FTIR spectroscopies of graphite and GO samples respectively.
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Figure 3.3: SEM and AFM images of graphite and graphite oxide. a, and
b, SEM images of graphite and graphite oxide. c, and d, AFM images of graphite and
graphite oxide respectively. The micrograph obtained through deposition on silicon
substrate.
3.1.2 Size reduction of graphene oxide particles
The size of graphene oxide particles is considered as important parameter in
cell viability investigation, therefore most studies recommend to reduce their
dimension.29,41,89,122 In this part, the ultra-sonication was performed in water
under variable conditions; the sonication was maintained at low (15 - 17 watt)
and high (26.5 - 28 watt) power for all samples. Two concentrations were selected
and considered as low (0.15 mg.ml−1) and high (3 mg.ml−1) concentrations.
The effect of power and concentration were measured at 30, 60 and 120 minutes
of sonication.
As shown in fig. 3.4 panel (a) and (b), the intensity ratio (ID/IG) increased
over 30 min of sonication for both power and concentration respectively, this
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result is attributed to the increment of the outer surface area of GO samples.
From 30 to 120 min sonication, the effect of time vanish and small change on
the surface area observed indicating that the size distribution of GO particles
slightly reduced.
Panel (c) and (d) demonstrated special type of sp3 defect (C-H group) appeared
at 2960 cm−1, this group is sensitive to the power and concentration; at low
power in panel (c), the concentration of GO is dominant, however, as seen in
panel (d), high power is sufficient to increase the intensity ratio of (C-H/G) at
low and high concentration, this results suggest that high power creates more
C-H groups at low and high concentration.
For more understanding of size reduction, SEM and AFM are used to
visualize the particles and measure their dimensions.
The statistical analysis of ca. 370 GO particles deduced from SEM and AFM
images provide clear information about the size reduction at different time,
power and sonication conditions. It was found that the GO particles reduced
over 30 min of sonication, with respect to lateral width (fig. 3.5a) the power of
sonication is crucial especially over 120 min of sonication.
However, the height distribution of GO particles is concentration dependent
even at low or high power of sonication (fig. 3.5b). As a result, high power of
sonication for 120 min destructs the flakes of GO to small parts, whilst at low
power the flakes can be easily exfoliated due to van der Waals interaction.
The optimal conditions for size reduction of GO particles can be considered at
high power and high concentration for 120 min of sonication.
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Figure 3.4: Data analysis of Raman spectroscopy at controlled sonication
conditions. a, and b, Intensity ratio I(D/G) of graphite oxide at low and high power
of sonication respectively. c, and d, Intensity ratio I(C-H/G) of GO at low and high
power of sonication. The data deduced from Raman measurements.
ba
Figure 3.5: Data analysis of SEM and AFM images at controlled sonication
conditions. a, Lateral and b, Height distribution of GO at variable sonication
conditions. The data deduced from SEM and AFM images respectively.
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3.1.3 Centrifugation of NGO particles in sucrose solutions
The sucrose density gradient solutions are mainly used to separate the nano -
scaled particles via centrifugation.28,96,123 The NGO particles distributed along
the centrifuge tube depending on the sucrose viscosity. The small sizes of NGO
remain in the upper zone, while the bigger sizes migrate to the bottom of the
tube where the viscosity of sucrose is relatively high. The centrifugation speed,
time and NGO concentration were optimized as controlled parameters. Along
the centrifuge tube (fig. 3.6a), three zones were observed indicating that the
mixture has three sizes of NGO particles.
From SEM images (fig. 3.7a - c) and statistical analysis (panel b, fig. 3.6), the
three layers of NGO named L1, L2 and L3 disclose three sizes at 100 nm, 200
nm and 300 nm respectively.
The height samples (fig. 3.6c) deduced from AFM micrograph (fig. 3.7d - f)
remain approximately the same for the three sizes.
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Figure 3.6: Statistical analysis of NGO particles deduced from microscopic
images. a, Photograph of centrifuge tube over 5 min centrifugation at 5880 g. b,
Histogram of the Lateral width of observed NGO sheets deduced from SEM images.
c, Histogram of the height distribution of observed NGO sheets deduced from AFM
images.
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Figure 3.7: SEM and AFM images of NGO particles. a, b and c, SEM images
of NGO 100 nm, 200 nm and 300 nm respectively. d, e and f, AFM images of NGO
100 nm, 200 nm and 300 nm respectively. (n.b.: The NGO was deposited on silicon
substrates for measurement)
3.2 NGO-PAMAM/CP nanohybrids
3.2.1 Spectroscopic analysis of NGO-PAMAM
To make NGO particles truly long-term stable and dispersible in physiological
media, it is important to functionalize the surface of NGO sheets by suitable
bio-molecules. The functionalization of NGO particles can be performed by
covalent and non-covalent approaches. It has been found that both the covalent
and non-covalent functionalization reduce the oxygen-containing species and
show functionalized NGO is biocompatible.
In this study, a zero generation polyamidoamide dendrimer (PAMAM-G0)
is used for covalent functionalization. PAMAM-G0 consists of alkyl-diamine
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core and terminates with four amine (-NH2) groups,98,99 these groups play a key
role in covalent amide bond formation via a ring opening reaction.28,109,124
After functionalization as shown in fig. 3.8, carboplatin, anticancer thera-
peutic agent is loaded to obtain NGO-PAMAM/CP nanohybrids.
Figure 3.8: Schematic illustration of NGO-PAMAM/CP preparation. 1,
Chemical oxidation exfoliation reaction. 2, Size reduction and functionalization by
PAMAM. 3, Carboplatin loading.
1. FTIR spectroscopy; fig. 3.9a presents the FTIR spectra of the
samples using NGO with the mean diameter of 100 nm.
The FTIR spectra of NGO functionalized with PAMAM and loaded with CP
show a relative reduction in the oxygen containing groups. The absorption
peaks of C=O at 1700 cm−1, the OH stretching mode ranging from 1425 to
1225 cm−1 and the C-O-C stretching modes showed a drastic decrease after
functionalization.51
These observations are attributed to the PAMAM which terminates with amine
(-NH2) groups covalently bonding with NGO epoxy groups via a ring opening
reaction.
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In fig. 3.9a, as compared to spectrum 1, new peaks at 1635 cm−1 (amide I) and
1552 cm−1 (amide II) can be seen in the spectra labeled 3 and 4 and arise due
to the presence of PAMAM in the sample. This is further highlighted when
comparing the spectra of PAMAM and CP films (fig. 3.9d), the presence of
peaks at 1635 cm−1 (amide I) and 1552 cm−1 (amide II) are clearly observed
in the PAMAM sample. We cannot clearly observe responses due to the C-N
bond between the NGO and PAMAM, because PAMAM has the same bond in
the same frequency region.125 The absorption peaks at 1620 cm−1 (C=O) and
1355 cm−1 (C-O) were used as indications for effective loading of CP.
Similar FTIR spectra for the other NGO samples (NGO 200 nm and 300 nm)
are provided in panel b and c (fig. 3.9) respectively.
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Figure 3.9: FTIR spectra of NGO particles, pure PAMAM, CP and
CP@PAMAM samples. a, FTIR spectra of pristine NGO 100 nm (1), CP@NGO
(2), PAMAM-NGO (3) and CP@PAMAM-NGO (4). b, NGO 200 nm (1), CP@NGO
(2), PAMAM-NGO (3) and CP@PAMAM-NGO (4). c, NGO 300 nm (1), CP@NGO
(2), PAMAM-NGO (3) and CP@PAMAM-NGO (4). d, ATR-FTIR spectra of CP (1),
PAMAM (2) and CP-PAMAM (3).
3.2. NGO-PAMAM/CP nanohybrids 49
2. XPS analysis; the NGO samples were also characterized using X-ray
photo-electron spectroscopy (XPS).
As shown in fig. 3.10a, the C1s spectrum of NGO 100 nm can be de-convoluted
to show five components that correspond to various functional groups, the
binding energies of the de-convoluted peaks centered at 284.2 eV, 285.7 eV,
286.7 eV, 287.5 eV and 288.4 eV are assigned to the graphene oxide sp2 carbon
skeleton (C-C/C=C), hydroxyl (-OH), epoxy (C-O-C), carbonyl (C=O) and
carboxyl groups (COOH) respectively.7,111
The C1s spectra of PAMAM-NGO 100 nm, CP@NGO and CP/PAMAM-
NGO exhibit the same oxygen containing functional groups as shown in fig.
3.10(b-d), however their peak intensities are reduced in comparison with pristine
NGO, indicating considerable de-oxygenation due to functionalization. Moreover,
the C1s spectra of PAMAM-NGO and CP/PAMAM-NGO are assigned two
additional peaks for C-N and C(O)-N bonds at 286.1 eV and 287.5 eV respectively
which have binding energies similar to those of C-OH and C=O respectively.100
On the other hand, these observations are consistent with the N1s XPS spectra
(fig. 3.11a), which clearly indicate the presence of nitrogen groups at 398.8 eV
(N-C) and 399.7 eV (N-C(O)),126,127 this suggests that the covalent bonding of
the amine terminated PAMAM onto the NGO surface via epoxide ring opening
reaction is in agreement with the FTIR data.
With regard to the O1s spectra they complement the C1s spectra in
that similar trends for the oxygen based functional groups were obtained. Fig.
3.11b shows the Pt4f (7/2) and Pt4f (5/2) peaks from the CP@NGO sample
confirming the immobilization of Pt (II) on the NGO surface through non-
covalent interactions such as van der Waals, H-π, cation-π interactions.128,129
The XPS spectra of NGO 200 nm, 300 nm and their functionalization
with PAMAM and CP loading show comparable trends due to their structural
similarity (fig. A.1 - A.3 in appendix).
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Figure 3.10: C1s and O1s XPS spectra of NGO 100 nm and PAMAM
functionalized materials. a - d, C1s XPS spectra of NGO 100 nm, CP@NGO,
PAMAM-NGO and CP@PAMAM-NGO respectively. e - h, O1s XPS spectra of NGO
100 nm, CP@NGO, PAMAM-NGO and CP@PAMAM-NGO respectively.
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Figure 3.11: N1s and Pt4f XPS spectra of NGO 100 nm and PAMAM
functionalized materials. a, N1s and b, Pt4f XPS spectra of pristine NGO 100 nm
(1), CP@NGO (2), PAMAM-NGO (3) and CP@PAMAM-NGO (4).
3.2.2 Cell culture and anticancer activity
The efficiency of the synthesized materials as a drug delivery system for a
commonly used anticancer drug (CP) was evaluated in HeLa cancer cell lines
and their biocompatibility in human mesenchymal stem cells (hMSCs).
The anticancer activity of the nanocomposite was tested by means of the WST-8
assays for studying the effect on HeLa cells, its biocompatibility was assessed on
hMSCs which represent a good model of non-malignant cells, the assay measures
the formation of a formazan product as an index of the cellular mitochondrial
dehydrogenase activity.
For the viability tests, two different concentrations of CP (10 and 20
μg.ml−1) were chosen, and by considering the loading value, 50 and 100
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mg.ml−1composite concentrations were also tested.
First, the activity of the three components (PAMAM, CP and NGO 100
nm) on cell viability was tested (fig. 3.12). In panel (a and b), as expected,
PAMAM did not show any kind of cytotoxicity on both hMSCs and HeLa
cells, the cell viability values of these samples were always higher than 98%,
which is an important parameter when considering further use of the composite
material.
Furthermore, CP shows the typical anticancer activity on HeLa cancer
cells (fig. 3.12b), which is mainly related to the formation of intra-strand DNA-
platinum adducts as previously demonstrated by Zanellato and co-workers.130
The presence of the PAMAM did not affect the anticancer activity of the CP, con-
firming the suitability of PAMAM for functionalizing the NGO nanoplatelets.
Significant results were obtained when pristine NGO samples were tested
on HeLa cancer cells (fig. 3.12c and d), the effect on cell viability was found to
be dependent on the NGO concentration (50 and 100 μg.ml−1)). Moreover, a
strong correlation between the particles’ size and the cells’ viability was observed,
this correlation suggests that cell death is related to the increased size of the
NGO. This finding does not seem to be in agreement with literature data,71 the
discrepancy is related to different mechanisms of cell death, literature data refer
to ROS-mediated phenomena occurring inside cells after NGO internalization,
while in our case, cell death has to be ascribed to physical damage of the cell
membrane due to an accumulation of big NGO clusters.
This phenomenon is very important in toxicological effects especially on
adherent cells because it induces damage on the cellular membrane and greatly
inhibits nutrient availability for cells. NGO with small particle sizes (e.g. NGO
100 nm) are well dispersed into the cell culture media, and thus they are able
to easily penetrate cells by endocytosis. As a consequence, the toxicity is only
related to the intracellular oxidative stress. In contrast, bigger sized NGO (e.g.
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NGO 300 nm) is not well dispersed in the cell culture media, and thus bigger
agglomerates can be observed. The formed NGO bundles in the media can
accumulate on the cellular membrane, therefore damaging or interfering with
cellular behavior.
The presence of PAMAM on the NGO surface greatly enhances the water affinity,
as a result the samples are well dispersed and less toxic to the cells.
The modification of the NGO surface also leads to less toxic materials
because the interaction with the cell membranes is mainly driven by the PAMAM.
When compared to the pristine NGO, the PAMAM functionalization was found
to increase the cell viability value up to 85% in the case of NGO 200 nm and
97% in NGO 100 nm samples. The PAMAM functionalization was ineffective in
increasing the biocompatibility of NGO 300 nm, which shows strong side effects
on the cells with a viability value of 25%, as the dendrimer was unable to better
disperse the NGO. The potential to employ the proposed composite materials as
drug delivery systems is arrived at by the evaluation of the anticancer activity
of the samples after loading with CP, which strongly interacts with the NGO
component by virtue of π - π interactions. As a loading protocol, a solvent
evaporation method was selected, to achieve for all samples a loading efficiency
of 100% and the same ratio (by weight) between drug and material (NGO or
PAMAM-NGO).
The anticancer activity of CP loaded samples of NGO 300 nm was very
high, but this effect is related to the NGO and it is independent of the anticancer
drug. The recorded anticancer activity is practically unmodified when compared
with pure NGO samples of 300 nm; NGO was, indeed, much more toxic than
the pure CP and thus the effect of the drug cannot be distinguished.
In the composite materials based on NGO 200 nm and NGO 100 nm, after
drug loading, very different results were obtained, the drug efficiency is greatly
enhanced and there are no indications that the activity is ascribed to the carrier
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itself (PAMAM-NGO). In particular they appear to be less toxic (PAMAM-NGO
200 nm) or non-toxic (PAMAM-NGO 100 nm), this finding confirms that when
modified with PAMAM, NGO easily penetrates inside the cells by endocytosis,71
and thus CP is more efficiently internalized. As a consequence, a local increase
in CP intracellular concentration occurs, leading to a higher amount of dead
cells. Specifically, while pure CP was able to kill 10 - 12% of cells, after its
loading with NGO, the anticancer activity increases up to 39% and 46% for the
100 nm and 200 nm composites, respectively, at the same drug concentration.
These values are almost four times more effective than that of the pure
drug. From the analysis of these results, the PAMAM-NGO 100 nm was found to
be the most promising material to be used as an effective intracellular delivery
system for anticancer therapeutics, it showed no toxicity to non-malignant
cells and high killing effect on cancer cells, as a consequence of the different
cell metabolism,101,102 these results show that because of the loading onto
NGO, less amount of CP can be used to achieve the same anticancer activity.
The possibility to use less of the drug while maintaining the same efficacy is
advantageous from both pharmaceutical and toxicological points of view.
To check the real suitability of these carriers, biocompatibility experiments
were conducted on non-neoplastic cells, this provides key information on how
the drug carrier is tolerated by non-cancerous cells. For this, our samples were
tested on hMSCs, as shown in fig. 3.12a and according to literature data,71 pure
NGO was highly toxic to hMSCs, but its biocompatibility was greatly enhanced
after functionalization with the PAMAM (cell viability: 96%), confirming the
high potential application of our proposed nanocomposite system.
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Figure 3.12: Percent viability of pure materials and functionalized NGO
particles. a, and b, Percent viability of mesenchymal and HeLa cells investigated by
pure materials respectively. c, and d, Percent viability of mesenchymal and HeLa cells
investigated by pristine NGO samples and nanohybrid systems at low (50 μg.ml−1)
and high (100 μg.ml−1) concentrations respectively.
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3.3 NGO - gelatin/CP nanohybrids
3.3.1 Characterization of Gel_NGO nanohybrids
1. UV visible spectroscopy; the estimated amount of gelatin coated
NGO particles can be determined by using UV visible spectroscopy (A Shi-
madzu UV-vis-NIR, MPC - 3100 Model, Dual beam spectrometer with PbS
photomultiplier detector). Initially, standard gelatin solutions 2.0, 1.0, 0.8, 0.6,
0.5, 0.4, 0.3, 0.2 and 0.1 mg.ml−1 were prepared in distilled water, followed
by stirring at 40 ◦C for complete dissolution, 10 mg.ml−1 NGO solution was
reacted with gelatin at different concentrations. The absorbance of gelatin
solutions were recorded as shown in fig. 3.13a, (Inset figure represents the
calibration curve of gelatin for binding capacity calculation). The reaction was
taken place at 40 ◦C with stirring for 2 hours, the final product of Gel_NGO
was filtrated and washed three times with distilled water in order to remove
unbound gelatin. Unbound gelatin was collected and metered to exact volume
for binding capacity calculation, the binding capacity (q) can be estimated by
the following equation.
q =
(
Co−Ce
m
)
* V
Where q (mg.mg−1) is the amount of gelatin bound onto NGO, Co (mg.ml−1) is
the initial gelatin concentration, Ce is the concentration of gelatin unbound at
equilibrium (estimated from the calibration curve of gelatin standard solution
presented in fig. 3.13a, V is the total volume of mixture (10 ml) and m is the
mass of NGO (10 mg). As shown in fig. 3.13b, the maximum capacity of gelatin
to NGO is 4:1 wt.wt−1 ratio, indicating that no more gelatin molecules will
absorb by NGO particles.
A slight change appeared at different NGO sizes, NGO 100 nm consumed
more gelatin molecules than NGO 200 nm and NGO 300 nm (table 3.1), the
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result indicates that NGO 100 nm with more edges can have more efficiency to
bind with gelatin molecules. The percent efficiency of gelatin coated NGO can
be estimated by using the following equation.51,131
% efficiency =
(
Co−Ce
Co
)
* 100%
a
b
Figure 3.13: Binding capacity of gelatin coated NGO particles. a, UV-vis
absorption spectra of gelatin solutions at different concentrations, (a -i): 2.0, 1.0, 0.8,
0.6, 0.5, 0.4, 0.3, 0.2 and 0.1 mg.ml−1 respectively, (inset: calibration curve of gelatin).
b, Binding capacity of gelatin coated NGO particles at different sizes, blue curve
represents the percent efficiency of Gel_NGO 100 nm.
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Table 3.1: Binding capacity of gelatin coated NGO and percent efficiency
Gel_NGO Gel_NGO q (mg/mg) Gel_NGO
ratio 100 nm Gel_NGO Gel_NGO Gel_NGO 100 nm
wt/wt Ce (mg/mg) 300 nm 200 nm 100 nm % efficiency
1:1 0.013 0.98 0.95 0.97 98.7
2:1 0.078 1.92 1.93 1.94 96.1
4:1 0.72 3.26 3.4 3.55 81.5
6:1 2.27 3.73 3.88 4.05 62.2
8:1 4.12 3.88 4.2 4.4 48.5
10:1 5.94 4.06 4.3 4.55 40.6
2. Raman spectroscopy; Raman spectra (fig. 3.14) provide the vibra-
tional regimes of graphite, pristine NGO and Gel_NGO nanohybrid materi-
als.118,132,133 The characteristic bands of graphite at 1360 cm−1, 1578 cm−1 and
2705 cm−1 which correspond to D-, G- and 2D-band respectively.
The sp2 carbon skeletal disorder induced D-band due to oxygen rich groups;
this band presumed as a key to emphasize the oxidation through the increment
of band width and integrated intensity. The G-band of graphite, sp2 (C-C)
bond appeared at 1578 cm−1 is an interesting band concerning its position and
full width at half maximum (FWHM).
NGO 100 nm revealed a significant change during oxidation in FWHM
and intensity ratio I (D/G) to 0.9 as a result of oxygen incorporation.105 The
2D-band at 2705 cm−1 denoted the second order of D-band and the number of
graphene layers, the functional groups on graphene basal plan or edges reduced
this band due to high structural disorder and exfoliation. The Gel_NGO at
different sizes show no considerable change in comparison with pristine NGO,
however the Raman shift in the G-band position by ca. 25 cm−1 could be
considered as indication for functionalization (fig. 3.14(c - e)).
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Figure 3.14: Raman spectra of gelatin functionalized NGO particles. a,
Graphite. b, Pristine NGO 100 nm. c - e, Gel_NGO 100 nm, 200 nm and 300 nm
respectively.
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3. X-ray photoelectron spectroscopy; the chemical state of pristine
NGO and Gel_NGO samples at all sizes were characterized using high resolution
X-ray photoelectron spectroscopy (XPS).
The C1s, O1s and N1s exhibit different components, indicating that these
elements have different chemical environments,28 the peaks were fitted with
Gaussian-Lorenzian mixed function, as shown in fig. 3.15a. The C1s peaks
appeared at 284.3 eV, 285.6 eV, 286.7 eV, 287.3 eV and 288.5 eV are ascribed to
sp2 hybrids (C-C / C=C), hydroxyl (-OH), epoxy (C-O-C), carbonyl (C=O)
and carboxyl (COOH) groups respectively.
The C1s spectra of CP@NGO 100 nm, Gel_NGO 100 nm and
CP@Gel_NGO 100 nm revealed at first glance the same oxygen groups as
shown in fig. 3.15(b - d), however NGO coated gelatin nanohybrid generates
two prominent peaks for C-N and C(O)-N bonds at 286.4 eV and 287.2 eV re-
spectively, which have binding energies closed to those of C-OH and C=O.124,134
These finding are consistent with the N1s XPS spectra (fig. 3.16a).
As shown in fig. 3.15(e - h), the O1s XPS spectra of pristine NGO and
functionalized samples were fitted to three main peaks around 531.2 eV, 532.07
eV and 533.01 eV, these peaks assigned to carboxyl, epoxide and hydroxyl
groups respectively and provide information complement with the information
obtained from C1s spectra. The C1s and O1s peak intensities of pristine NGO
reduced drastically after coating by gelatin, which attribute to deoxygenation.
Fig. 3.16b shows the Pt4f (7/2) and Pt4f (5/2) peaks originated from the
immobilization of Platinum in the samples containing carboplatin molecules,
confirming the noncovalent interactions such as van der Waals, π - π, H -
bonding, and cationic - π interactions with NGO particles.129,135
The XPS spectra of NGO 200 nm, 100 nm and functionalized materials
exhibit analogous trends due to their structural similarity (see in appendix fig.
A.4 - A.7).
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Figure 3.15: C1s and O1s XPS spectra of NGO 100 nm and gelatin func-
tionalized materials. a - d, C1s XPS spectra of NGO 100 nm, CP@NGO, Gel_NGO
and CP@Gel_NGO respectively. e - h, O1s XPS spectra of NGO 100 nm, CP@NGO,
Gel_NGO and CP@Gel_NGO respectively. All XPS data normalized at C - C peak
position.
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a b
Figure 3.16: N1s and Pt4f XPS spectra of NGO 100 nm and gelatin func-
tionalized materials. a, N1s and b, Pt4f XPS spectra of pristine NGO 100 nm (1),
CP@NGO (2), Gel_NGO (3) and CP@Gel_NGO (4) respectively.
4. Atomic force microscopy; fig. 3.17(a - c) shows AFM images of the
three different sizes of NGO, the thickness of selected particle is shown below
each image. The statistical analysis of about 250 particles of the three samples
confirmed the thickness of pristine NGO particles as appeared in fig. 3.17g,
the thickness for all samples is approximately 3.4 nm and the number of NGO
sheets is ca. 6 (assuming an interlayer distance of 0.7 nm).136
After gelatin functionalization, the thickness of NGO flakes increased up to
approximately 12 nm (panel h), indicating that gelatin shielded NGO particles
via noncovalent interaction (fig. 3.17(d-f)).
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Figure 3.17: AFM images and statistical data of NGO particles. a - c, AFM
images of pristine NGO 100 nm, 200 nm and 300 nm respectively. d - f, Gel_NGO
100 nm, 200 nm and 300 nm nanohybrids (n.b.: samples were deposited on silicon
substrates for measurements. g, and h, Histograms of the observed NGO particles at
different sizes and Gel_NGO nanohybrids respectively. The data deduced from AFM
images.
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3.3.2 Cell culture and anticancer activity
IMR-32 human neuroblastoma cells were used as a model for evaluating the
efficiency of the proposed nanohybrids to act as carriers for carboplatin which
is used for the treatment of various cancer. Here, we explore the strategy
of noncovalent modification via loading onto a hybrids nanocarrier, with the
aim to enhance the anticancer efficiency of the drug. All the samples were
tested at 5 μg.ml−1 CP equivalent concentration, corresponding to a nanohybrid
concentration of 25μg.ml−1. Any drug carrier and biomaterials proposed for
use in biomedicine need to strictly address the biocompatibility issues.71,137
The absence of any trace of toxic effect on non-malignant cells is the ideal
behavior for biomaterials, and in this work we used hMSCs as an effective
in vitro model for healthy cells. These cells were selected by virtue of their
metabolic pathways conferring them high susceptibility to foreign compounds
and biomaterials.137,138
In our previous work,28 the activity of NGO on hMSCs at a concentration
of 100 μg.ml−1 was analyzed. The results show a very high toxicity of the
pristine NGO, and even at the concentration tested here 25 μg.ml−1, the cell
viability value lower of ca. 30% is recorded, highlighting the need to functionalize
the NGO surface before any kind of biological application (fig. 3.18a). The
suitability of the proposed strategy of functionalizing NGO with gelatin was
proven when considering the recorded biocompatibility of the Gel_NGO samples,
which were found to have no effect on the cell viability.
Interestingly, gelatin as shown in fig. 3.19, is able to reduce the toxicity of all
sized NGO because of the formation of a protein shell around the nanoparticles,
allowing an easier NGO dispersion and preventing any kind of damage on the
cell surface. As expected, gelatin alone did not affect the cell viability, while
it was found to reduce the activity of the platinum drug. The CP efficiency is
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a
b
Figure 3.18: Viability percent of pure samples prior NGO functionalization.
a, Mesenchymal stem cells. b, IMR-32 cancer cells after 24 h of incubation.
reduced by almost 50%, since it moves from 41 to 62% for CP and CP@Gel,
respectively (fig. 3.18b), this behavior can be ascribed to the high molecular
weight of protein, which prevents CP entering cells.
When considering the activity of the CP loaded Gel_NGO samples, the
strong dependency between the efficiency and the size of the carriers is clearly
evident. Gel_NGO 300 nm and Gel_NGO 200 nm were found to not significantly
modify the drug activity, as assessed by the recorded cell viability close to that
66 3. Results and Discussion
Figure 3.19: Viability percent of NGO particles and functionalized
materials.
of the free form of the drug. Gel_NGO 100 nm denotes a completely different
behavior, since in this case the activity of the CP is almost doubled, with a cell
viability of 41 and 23%, for CP and CP@Gel_NGO 100 respectively.
The size dependency of the carrier efficiency is strictly related to their
ability to enter cells, and this is in agreement with data in literature showing
that lower sized NGO are able to strongly interact with the cell environment
with a more efficient delivery of the hosted drug. This denotes the ability of
the carrier to increase the local concentration of the drug inside the cells, thus
resulting in enhanced activity. This is of tremendous importance when thinking
of potential clinical applications, since it is possible to dramatically reduce the
drug doses, with the advantages of reducing systemic side effects. Gel_NGO
100 nm and CP have a synergistic activity, offering potential enhancement of
drug desired properties, such as increased water solubility, cellular uptake and
targeted delivery and thus the development of a combination therapeutic protocol
involving the use of the proposed nanohybrid carrier can be hypothesized.
4
Conclusion
This thesis demonstrates the synthesis of Nanographene oxide with well-defined
sizes from natural graphite by using oxidation exfoliation reaction. The ex-
ceptional chemical structure of graphene oxide due to the presence of oxygen
containing groups offers covalent and noncovalent functionalization, which over-
tures to exciting prospects in biological applications.
In this work, NGO particles have been functionalized by PAMAM and
gelatin via covalent and noncovalent interactions respectively, yielding NGO-
PAMAM and Gel_NGO nanohybrids with high dispersibility and stability in
physiological media, as well as reducing cytotoxicity toward HeLa and Neurob-
lastoma cells. The comparative toxicities of three sizes of pristine NGO are
different, the results highlight the potential of low dimensional (ca. 100 nm)
NGO as functional tool for enhancing carboplatin activity in cancer cell lines.
The size of NGO is considered as a crucial key in how they interact with cells and
other biological systems. The investigated nanohybrid materials, particularly
with low NGO sizes, exhibit no obvious toxicity to in vitro cell culture mod-
els, The results suggest that functionalization of NGO by using biocompatible
substances will reduce the oxidative stress which is one of mechanisms consid-
ered in cytotoxic effects of NGO particles. In vitro studies revealed that such
nanohybrid materials could offer a platform for targeted carboplatin delivery,
raise the cellular uptake and controlled drug release in biological system.
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Owing to its small size, large specific surface area, various oxygen groups,
low cost, and mostly no cytotoxicity to human stem cells, the NGO-PAMAM
and Gel_NGO could be considered as exciting nanohybrids to have broad
biological applications.
The lower sized NGO 100 nm coated gelatin exhibits excellent stability
and biocompatibility in cell culture media according to their potency to interact
with cellular membrane. A synergistic activity between CP and carrier was
recorded, as suggested by the enhanced efficiency in CP in killing cancer cells
after loading onto the Gel_NGO. Interestingly, the cell viability was not affected
by Gel_NGO, confirming that the recorded anticancer activity is related to
an increased local concentration of the drug inside the cells, thus resulting in
enhanced activity. Further investigation should be done to this regard, but
the data reported have evidenced a very promising starting point for further
research by chemists, nanotechnologists, biologists and oncologists.
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Figure A.1: C1s and O1s XPS spectra of NGO 200 nm and PAMAM func-
tionalized materials. a - d, C1s XPS spectra of NGO 200 nm, CP@NGO, PAMAM-
NGO and CP@PAMAM-NGO respectively. e - h, O1s XPS spectra of NGO 200 nm,
CP@NGO, PAMAM-NGO and CP@PAMAM-NGO respectively.
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Figure A.2: C1s and O1s XPS spectra of NGO 300 nm and PAMAM func-
tionalized materials. a - d, C1s XPS spectra of NGO 300 nm, CP@NGO, PAMAM-
NGO and CP@PAMAM-NGO respectively. e - h, O1s XPS spectra of NGO 300 nm,
CP@NGO, PAMAM-NGO and CP@PAMAM-NGO respectively.
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Figure A.3: N1s and Pt4f XPS spectra of NGO 300 nm and PAMAM
functionalized materials. a, N1s and b, Pt4f XPS spectra of pristine NGO 300 nm
(1), CP@NGO (2), PAMAM-NGO (3) and CP@PAMAM-NGO (4).
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Figure A.4: C1s and O1s XPS spectra of NGO 200 nm and gelatin function-
alized materials. a - d, C1s XPS spectra of NGO 200 nm, CP@NGO, Gel_NGO
and CP@Gel_NGO respectively. e - h, O1s XPS spectra of NGO 200 nm, CP@NGO,
Gel_NGO and CP@Gel_NGO respectively. All XPS data normalized at C - C peak
position.
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Figure A.5: C1s and O1s XPS spectra of NGO 300 nm and gelatin function-
alized materials. a - d, C1s XPS spectra of NGO 300 nm, CP@NGO, Gel_NGO
and CP@Gel_NGO respectively. e - h, O1s XPS spectra of NGO 300 nm, CP@NGO,
Gel_NGO and CP@Gel_NGO respectively. All XPS data normalized at C - C peak
position.
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Figure A.6: N1s and Pt4f XPS spectra of NGO 200 nm and gelatin func-
tionalized materials. a, N1s and b, Pt4f XPS spectra of pristine NGO 200 nm (1),
CP@NGO (2), Gel_NGO (3) and CP@Gel_NGO (4) respectively.
a b
Figure A.7: N1s and Pt4f XPS spectra of NGO 300 nm and gelatin func-
tionalized materials. a, N1s and b, Pt4f XPS spectra of pristine NGO 300 nm (1),
CP@NGO (2), Gel_NGO (3) and CP@Gel_NGO (4) respectively.
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